Studying the relationship between autism spectrum disorder and cancer in individuals affected by PTEN hamartoma tumor syndrome is the subject of a new $2 million grant awarded from the National Institutes of Health to Charis Eng, MD, PhD, Chair of the Genomic Medicine Institute.
Cleveland Clinic Forms Center for Research Excellence in Gynecologic Cancer
The Cleveland Clinic Center for Research Excellence in Gynecologic Cancer (CREGC) is a collaborative network for the development of a comprehensive research program to promote the translation of basic science investigation into the clinic.
Research Team Identifies GATA4 Loss-of-Function as Oncogenic in Hepatocellular Carcinoma
Cleveland Clinic Cancer Center researchers have identified a genetic alteration that plays a central role in the development of liver cancer and may lead to effective new treatments.
Mouse Patient Avatars Serve as Improved Models of Cancer Therapy Resistance
Cleveland Clinic researchers identify genomic determinants for resistance to cancer therapies using large-scale tumor genomic profiling and patient-derived xenografts.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy